Previous multi-cohort meta-analyses and experimental studies confirmed that MMP9 and S100A8/A9 contribute to microglial activation and neuronal injury [47,48], while CCL2 signaling has been linked to neurodegeneration and immune cell recruitment in Huntington’s disease [49]. This evidence concerns the gene CCL2 and Huntington disease.